Dr. Andreas  Scorilas
My Social Links

Dr. Andreas Scorilas

Professor
National and Kapodistrian University of Athens, Greece


Highest Degree
PostDoc. in Clinical Biochemistry from University of Toronto, Canada

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Pharmaceutical Sciences
62%
Clinical Biochemistry
90%
Molecular Biology
75%
Herbal Medicine
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Tsikrika, F.D., M. Avgeris, P.K. Levis, T. Tokas, K. Stravodimos and A. Scorilas, 2018. miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression. Genes Chromosomes Cancer, 57: 150-161.
    CrossRef  |  Direct Link  |  
  2. Kyriakou, I.K., K. Mavridis, D.P. Kalogianni, T.K. Christopoulos, P.C. Ioannou and A. Scorilas, 2018. Multianalyte quantitative competitive PCR on optically encoded microspheres for an eight-gene panel related to prostate cancer. Anal. Bioanal. Chem., 410: 971-980.
    CrossRef  |  Direct Link  |  
  3. White, N.M.A., O. Masui, D. Newsted, A. Scorilas and A.D. Romaschin et al., 2017. Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis. Br. J. Cancer, Vol. 116. 10.1038/bjc.2016.441.
    CrossRef  |  Direct Link  |  
  4. Tsangaris, G.T., C. Papathanasiou, P.G. Adamopoulos, A. Scorilas and C.E. Vorgias et al., 2017. Pediatric ependymoma: A proteomics perspective. Cancer Genom. Proteomics, 14: 127-136.
    Direct Link  |  
  5. Tokas, T., M. Avgeris, C. Alamanis, A. Scorilas, K.G. Stravodimos and C.A. Constantinides, 2017. Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis. J. Cancer Res. Clin. Oncol., 143: 521-532.
    CrossRef  |  Direct Link  |  
  6. Rapti, S.M., C.K. Kontos, S. Christodoulou, I.N. Papadopoulos and A. Scorilas, 2017. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value. Clin. Biochem., 50: 918-924.
    CrossRef  |  Direct Link  |  
  7. Piatopoulou, D., M. Avgeris, A. Marmarinos, M. Xagorari and M. Baka et al., 2017. miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment. Br. J. Cancer, 117: 801-812.
    CrossRef  |  Direct Link  |  
  8. Parmakelis, A., P. Kotsakiozi, C.K. Kontos, P.G. Adamopoulos and A. Scorilas, 2017. The transcriptome of a “sleeping” invader: De novo assembly and annotation of the transcriptome of aestivating Cornu aspersum. BMC Genom., Vol. 18. 10.1186/s12864-017-3885-1.
    CrossRef  |  Direct Link  |  
  9. Kontos, C.K., S.G. Papageorgiou, M.A. Diamantopoulos, A. Scorilas and E. Bazani et al., 2017. mRNA overexpression of the hypoxia inducible factor 1 alpha subunit gene (HIF1A): An independent predictor of poor overall survival in chronic lymphocytic leukemia. Leukemia Res., 53: 65-73.
    CrossRef  |  PubMed  |  Direct Link  |  
  10. Kontos, C.K., P. Tsiakanikas, M. Avgeris, I.N. Papadopoulos and A. Scorilas, 2017. miR-15a-5p, a novel prognostic biomarker, predicting recurrent colorectal adenocarcinoma. Mol. Diagn. Ther., 21: 453-464.
    CrossRef  |  Direct Link  |  
  11. Khella, H.W., N. Daniel, L. Youssef, A. Scorilas and R. Nofech-Mozes et al., 2017. miR-10b is a prognostic marker in clear cell renal cell carcinoma. J. Clin. Pathol., 70: 854-859.
    CrossRef  |  Direct Link  |  
  12. Kerimis, D., C.K. Kontos, S. Christodoulou, I.N. Papadopoulos and A. Scorilas, 2017. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Clin. Biochem., 50: 285-292.
    CrossRef  |  Direct Link  |  
  13. Kapodistrias, N., K. Mavridis, A. Batistatou, P. Gogou and V. Karavasilis et al., 2017. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis. Oncotarget, 8: 6896-6913.
    CrossRef  |  Direct Link  |  
  14. Galtsidis, S., S. Logotheti, A. Pavlopoulou, C.P. Zampetidis and G. Papachristopoulou et al., 2017. Unravelling a p73-regulated network: The role of a novel p73-dependent target, MIR3158, in cancer cell migration and invasiveness. Cancer Lett., 388: 96-106.
    CrossRef  |  Direct Link  |  
  15. Diamantopoulos, M.A., C.K. Kontos, D. Kerimis, I.N. Papadopoulos and A. Scorilas, 2017. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients. Clin. Chem. Lab. Med., 55: 737-747.
    CrossRef  |  Direct Link  |  
  16. Christodoulou, M.I. and A. Scorilas, 2017. Metformin and anti-cancer therapeutics: Hopes for a more enhanced armamentarium against human neoplasias. Curr. Med., Chem., 24: 14-56.
    Direct Link  |  
  17. Adamopoulos, P.G., C.K. Kontos and A. Scorilas, 2017. Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5-KLK9), using NEXT-generation sequencing. Scient. Rep., Vol. 7. 10.1038/s41598-017-16269-6.
    CrossRef  |  Direct Link  |  
  18. Adamopoulos, P.G., C.K. Kontos and A. Scorilas, 2017. Identification and molecular cloning of novel transcripts of the human kallikrein-related peptidase 10 (KLK10) gene using next-generation sequencing. Biochem. Biophys. Res. Commun., 487: 776-781.
    CrossRef  |  Direct Link  |  
  19. Vassilakopoulou, M., M. Avgeris, V. Velcheti, V. Kotoula and T. Rampias et al., 2016. Evaluation of PD-L1 expression and associated tumor-infiltrating lymphocytes in laryngeal squamous cell carcinoma. Clin. Cancer Res., 22: 704-713.
    CrossRef  |  Direct Link  |  
  20. Skourti, E., S. Logotheti, C.K. Kontos, A. Pavlopoulou and P.T. Dimoragka et al., 2016. Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir-200 family members, mir-205 and their common targets. Mol. Carcinog., 55: 1229-1242.
    CrossRef  |  Direct Link  |  
  21. Rapti, S.M., C.K. Kontos, I.N. Papadopoulos and A. Scorilas, 2016. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis. Tumor Biol., 37: 11815-11824.
    CrossRef  |  Direct Link  |  
  22. Papageorgiou, S.G., C.K. Kontos, P.G. Foukas, E. Panopoulou and D. Vasilatou et al., 2016. BCL2L12 protein overexpression is associated with favorable outcome in diffuse large B-cell lymphoma patients in the rituximab era. Leukemia Lymphoma, 57: 2199-2203.
    CrossRef  |  Direct Link  |  
  23. Papadopoulos, E.I., C. Petraki, A. Gregorakis, E.G. Fragoulis and A. Scorilas, 2016. Clinical evaluation of microRNA-145 expression in renal cell carcinoma: A promising molecular marker for discriminating and staging the clear cell histological subtype. Biol. Chem., 397: 529-539.
    CrossRef  |  Direct Link  |  
  24. Nofech-Mozes, R., H.W. Khella, A. Scorilas, L. Youssef and S.N. Krylov et al., 2016. MicroRNA-194 is a marker for good prognosis in clear cell renal cell carcinoma. Cancer Med., 5: 656-664.
    CrossRef  |  Direct Link  |  
  25. Kontos, C.K., P.G. Adamopoulos, S.G. Papageorgiou, V. Pappa and A. Scorilas, 2016. mRNA overexpression of kallikrein-related peptidase 14 (KLK14) is an independent predictor of poor overall survival in chronic lymphocytic leukemia patients. Clin. Chem. Lab. Med., 54: 315-324.
    CrossRef  |  Direct Link  |  
  26. Giotakis, A.I., C.K. Kontos, L.D. Manolopoulos, A. Sismanis, M.M. Konstadoulakis and A. Scorilas, 2016. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis. Clin. Biochem., 49: 890-896.
    CrossRef  |  Direct Link  |  
  27. Dalloneau, E., N. Baroukh, K. Mavridis, A. Maillet and F. Gueugnon et al., 2016. Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis. Oncotarget, 7: 54415-54429.
    CrossRef  |  Direct Link  |  
  28. Avgeris, M. and A. Scorilas, 2016. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies. Exp. Opin. Ther. Tar., 20: 801-818.
    CrossRef  |  Direct Link  |  
  29. Adamopoulos, P.G., C.K. Kontos, P. Tsiakanikas and A. Scorilas, 2016. Identification of novel alternative splice variants of the BCL2L12 gene in human cancer cells using next-generation sequencing methodology. Cancer Lett., 373: 119-129.
    CrossRef  |  Direct Link  |  
  30. White-Al Habeeb, N.M., A. Di Meo, A. Scorilas, F. Rotondo and O. Masui et al., 2015. Alpha-enolase is a potential prognostic marker in clear cell renal cell carcinoma. Clin. Exp. Metastasis, 32: 531-541.
    CrossRef  |  Direct Link  |  
  31. Stamati, L., M. Avgeris, H. Kosmidis, M. Baka and T. Anastasiou et al., 2015. Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients' poor response to treatment and short-term relapse. J. Cancer Res. Clin. Oncol., 141: 2023-2036.
    CrossRef  |  Direct Link  |  
  32. Samaan, S., H.W. Khella, A. Girgis, A. Scorilas and E. Lianidou et al., 2015. miR-210 is a prognostic marker in clear cell renal cell carcinoma. J. Mol. Diagn., 17: 136-144.
    CrossRef  |  Direct Link  |  
  33. Papadopoulos, E.I., G.M. Yousef and A. Scorilas, 2015. Gemcitabine impacts differentially on bladder and kidney cancer cells: Distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes. Tumor Biol., 36: 3197-3207.
    CrossRef  |  Direct Link  |  
  34. Papadopoulos, E.I., G.M. Yousef and A. Scorilas, 2015. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes. Biomed. Pharmacother., 70: 33-40.
    CrossRef  |  Direct Link  |  
  35. Papadopoulos, E.I., E.G. Fragoulis and A. Scorilas, 2015. Human L-DOPA decarboxylase mRNA is a target of miR-145: A prediction to validation workflow. Gene, 554: 174-180.
    CrossRef  |  Direct Link  |  
  36. Papadopoulos, E.I., C. Petraki, A. Gregorakis, E. Chra, E.G. Fragoulis and A. Scorilas, 2015. L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma. Clin. Biochem., 48: 590-595.
    CrossRef  |  Direct Link  |  
  37. Papadopoulos, E.I. and A. Scorilas, 2015. Cisplatin and paclitaxel alter the expression pattern of miR-143/145 and miR-183/96/182 clusters in T24 bladder cancer cells. Clin. Transl. Sci., 8: 668-675.
    CrossRef  |  Direct Link  |  
  38. Miltiades, P., E. Lamprianidou, T.P. Vassilakopoulos, S.G. Papageorgiou and A. Galanopoulos et al., 2015. The Stat3/5 signaling biosignature in hematopoietic stem/progenitor cells predicts response and outcome in myelodysplastic syndrome patients treated with azacitidine. Clin. Cancer Res., 22: 1958-1968.
    CrossRef  |  PubMed  |  Direct Link  |  
  39. Michaelidou, K., A. Ardavanis and A. Scorilas, 2015. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: A novel independent indicator of disease-free survival. Breast Cancer Res. Treat., 152: 323-336.
    CrossRef  |  Direct Link  |  
  40. Luchini, C., N. Veronese, M. Solmi, H. Cho and J.H. Kim et al., 2015. Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: A systematic review and meta-analysis. Oncotarget, 6: 39088-39097.
    CrossRef  |  Direct Link  |  
  41. Kontos, C.K., P.G. Adamopoulos and A. Scorilas, 2015. Prognostic and predictive biomarkers in prostate cancer. Expert Rev. Mol. Diagn., 15: 1567-1576.
    CrossRef  |  Direct Link  |  
  42. Kladi-Skandali, A., K. Michaelidou, A. Scorilas and K. Mavridis, 2015. Long noncoding RNAs in digestive system malignancies: A novel class of cancer biomarkers and therapeutic targets. Gastroenterol. Res. Pract., 10.1155/2015/319861.
    CrossRef  |  Direct Link  |  
  43. Khella, H.W., A. Scorilas, R. Mozes, L. Mirham and E. Lianidou et al., 2015. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma. Am. J. Pathol., 185: 693-703.
    CrossRef  |  Direct Link  |  
  44. Karamchandani, J.R., M.Y. Gabril, R. Ibrahim, A. Scorilas and E. Filter et al., 2015. Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma. Hum. Pathol., 46: 673-680.
    CrossRef  |  Direct Link  |  
  45. Karaliotas, G.I., K. Mavridis, A. Scorilas and G.C. Babis, 2015. Quantitative analysis of the mRNA expression levels of BCL2 and BAX genes in human osteoarthritis and normal articular cartilage: An investigation into their differential expression. Mol. Med. Rep., 12: 4514-4521.
    CrossRef  |  Direct Link  |  
  46. Gueugnon, F., A. Barascu, K. Mavridis, A. Petit-Courty and S. Marchand-Adam et al., 2015. Kallikrein-related peptidase 13: An independent indicator of favorable prognosis for patients with nonsmall cell lung cancer. Tumor Biol., 36: 4979-4986.
    CrossRef  |  Direct Link  |  
  47. Avgeris, M., K. Mavridis, T. Tokas, K. Stravodimos, E.G. Fragoulis and A. Scorilas, 2015. Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment. Carcinogenesis, 36: 528-537.
    CrossRef  |  Direct Link  |  
  48. Adamopoulos, P.G., C.K. Kontos, S.M. Rapti, I.N. Papadopoulos and A. Scorilas, 2015. miR-224 overexpression is a strong and independent prognosticator of short-term relapse and poor overall survival in colorectal adenocarcinoma. Int. J. Oncol., 46: 849-859.
    CrossRef  |  Direct Link  |  
  49. Adamopoulos, P.G., C.K. Kontos, S.G. Papageorgiou, V. Pappa and A. Scorilas, 2015. KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia. Clin. Biochem., 48: 849-854.
    CrossRef  |  Direct Link  |  
  50. Xu, C.H., Y. Zhang and L.K. Yu, 2014. The diagnostic and prognostic value of serum human kallikrein-related peptidases 11 in non-small cell lung cancer. Tumor Biol., 35: 5199-5203.
    CrossRef  |  Direct Link  |  
  51. White, N.M.A., O. Masui, D. Newsted, A. Scorilas and A.D. Romaschin et al., 2014. Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis. Br. J. Cancer, 110: 1250-1259.
    CrossRef  |  Direct Link  |  
  52. Vakrakou, A., M. Devetzi, G. Papachristopoulou, A. Malachias, A. Scorilas, D. Xynopoulos and M. Talieri, 2014. Kallikrein-related peptidase 6 (KLK6) expression in the progression of colon adenoma to carcinoma. Biol. Chem., 395: 1105-1117.
    CrossRef  |  Direct Link  |  
  53. Tzovaras, A., A. Kladi-Skandali, K. Michaelidou, G.C. Zografos, I. Missitzis, A. Ardavanis and A. Scorilas, 2014. BCL2L12: A promising molecular prognostic biomarker in breast cancer. Clin. Biochem., 47: 257-262.
    CrossRef  |  Direct Link  |  
  54. Scorilas, A. and K. Mavridis, 2014. Predictions for the future of kallikrein-related peptidases in molecular diagnostics. Exp. Rev. Mol. Diagn., 14: 713-722.
    CrossRef  |  Direct Link  |  
  55. Rapti, S.M., C.K. Kontos, I.N. Papadopoulos and A. Scorilas, 2014. Enhanced miR-182 transcription is a predictor of poor overall survival in colorectal adenocarcinoma patients. Clin. Chem. Lab. Med., 52: 1217-1227.
    CrossRef  |  Direct Link  |  
  56. Rampias, T., P. Vgenopoulou, M. Avgeris, A. Polyzos and K. Stravodimos et al., 2014. A new tumor suppressor role for the Notch pathway in bladder cancer. Nat. Med., 20: 1199-1205.
    CrossRef  |  Direct Link  |  
  57. Rampias, T., A. Giagini, S. Siolos, H. Matsuzaki, C. Sasaki, A. Scorilas and A. Psyrri, 2014. RAS/PI3K crosstalk and cetuximab resistance in head and neck squamous cell carcinoma. Clin. Cancer Res., 20: 2933-2946.
    CrossRef  |  Direct Link  |  
  58. Pavlopoulou, A. and A. Scorilas, 2014. A comprehensive phylogenetic and structural analysis of the Carcinoembryonic Antigen (CEA) gene family. Genome Biol. Evolut., 6: 1314-1326.
    CrossRef  |  Direct Link  |  
  59. Mavridis, K., M. Avgeris and A. Scorilas, 2014. Targeting kallikrein-related peptidases in prostate cancer. Exp. Opin. Ther. Targ., 18: 365-383.
    CrossRef  |  Direct Link  |  
  60. Kontos, C.K., M.I. Christodoulou and A. Scorilas, 2014. Apoptosis-related BCL2-family members: Key players in chemotherapy. Anti-Cancer Agents Med. Chem., 14: 353-374.
    CrossRef  |  PubMed  |  Direct Link  |  
  61. Girgis, H., O. Masui, N.M. White, A. Scorilas and F. Rotondo et al., 2014. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol. Cancer, Vol. 13. 10.1186/1476-4598-13-101.
    CrossRef  |  Direct Link  |  
  62. Foutadakis, S., M. Avgeris, T. Tokas, K. Stravodimos and A. Scorilas, 2014. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors. Urol. Oncol., 32: 39.e29-39.e36.
    CrossRef  |  Direct Link  |  
  63. Foteinou, E., C.K. Kontos, A.I. Giotakis and A. Scorilas, 2014. Low mRNA expression levels of kallikrein-related peptidase 4 (KLK4) predict short-term relapse in patients with laryngeal squamous cell carcinoma. Biol. Chem., 395: 1051-1062.
    CrossRef  |  Direct Link  |  
  64. Christodoulou, S., D.K. Alexopoulou, C.K. Kontos, A. Scorilas and I.N. Papadopoulos, 2014. Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma. Tumor Biol., 35: 4673-4685.
    CrossRef  |  Direct Link  |  
  65. Christodoulou, M.I., K.C. Kontos, M. Halabalaki, A.L. Skaltsounis and A. Scorilas, 2014. Nature promises new anticancer agents: Interplay with the apoptosis-related BCL2 gene family. Anti-Cancer Agents Med. Chem., 14: 375-399.
    Direct Link  |  
  66. Avgeris, M., K. Stravodimos and A. Scorilas, 2014. Loss of miR-378 in prostate cancer, a common regulator of KLK2 and KLK4, correlates with aggressive disease phenotype and predicts the short-term relapse of the patients. Biol. Chem., 395: 1095-1104.
    CrossRef  |  Direct Link  |  
  67. Alexopoulou, D.K., C.K. Kontos, S. Christodoulou, I.N. Papadopoulos and A. Scorilas, 2014. KLK11 mRNA expression predicts poor disease-free and overall survival in colorectal adenocarcinoma patients. Biomarkers Med., 8: 671-685.
    CrossRef  |  Direct Link  |  
  68. Theodorou, M., M. Speletas, A. Mamara, G. Papachristopoulou, V. Lazou, A. Scorilas and E. Katsantoni, 2013. Identification of a STAT5 target gene, Dpf3, provides novel insights in chronic lymphocytic leukemia. PLoS ONE, Vol. 8. 10.1371/journal.pone.0076155.
    CrossRef  |  Direct Link  |  
  69. Schmitt, M., V. Magdolen, F. Yang, M. Kiechle and J. Bayani et al., 2013. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies. Radiol. Oncol., 47: 319-329.
    Direct Link  |  
  70. Papachristopoulou, G., M. Talieri and A. Scorilas, 2013. Significant alterations in the expression pattern of kallikrein-related peptidase genes KLK4, KLK5 and KLK14 after treatment of breast cancer cells with the chemotherapeutic agents epirubicin, docetaxel and methotrexate. Tumor Biol., 34: 369-378.
    CrossRef  |  Direct Link  |  
  71. Michaelidou, K., A. Tzovaras, I. Missitzis, A. Ardavanis and A. Scorilas, 2013. The expression of the CEACAM19 gene, a novel member of the CEA family, is associated with breast cancer progression. Int. J. Oncol., 42: 1770-1777.
    CrossRef  |  Direct Link  |  
  72. Mavridis, K., K. Stravodimos and A. Scorilas, 2013. Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression. Prostate, 73: 1191-1201.
    CrossRef  |  Direct Link  |  
  73. Mavridis, K., K. Stravodimos and A. Scorilas, 2013. Downregulation and prognostic performance of microRNA 224 expression in prostate cancer. Clin. Chem., 59: 261-269.
    CrossRef  |  Direct Link  |  
  74. Lichner, Z., A. Scorilas, N.M. White, A.H. Girgis and L. Rotstein et al., 2013. The chromatin remodeling gene ARID1A is a new prognostic marker in clear cell renal cell carcinoma. Am. J. Pathol., 182: 1163-1170.
    CrossRef  |  Direct Link  |  
  75. Koumandou, V.L. and A. Scorilas, 2013. Evolution of the plasma and tissue kallikreins and their alternative splicing isoforms. PLoS ONE, Vol. 8. 10.1371/journal.pone.0068074.
    CrossRef  |  Direct Link  |  
  76. Korbakis, D., E.G. Fragoulis and A. Scorilas, 2013. Quantification and study of the L-DOPA decarboxylase expression in gastric adenocarcinoma cells treated with chemotherapeutic substances. Anti-Cancer Drugs, 24: 291-299.
    CrossRef  |  Direct Link  |  
  77. Kontos, C.K., K. Mavridis, M. Talieri and A. Scorilas, 2013. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer:Mechanistic and clinical aspects. Thrombosis Haemostasis, 110: 450-457.
  78. Kontos, C.K., D. Chantzis, I.N. Papadopoulos and A. Scorilas, 2013. Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients. Cancer Lett., 330: 106-112.
    CrossRef  |  Direct Link  |  
  79. Kontos, C.K., A. Scorilas and A.G. Papavassiliou, 2013. The role of transcription factors in laboratory medicine. Clin. Chem. Lab. Med., 51: 1563-1571.
    CrossRef  |  Direct Link  |  
  80. Kontos, C.K., A. Fendri, A. Khabir, R. Mokdad-Gargouri and A. Scorilas, 2013. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: A retrospective cohort study. BMC Cancer, Vol. 13. 10.1186/1471-2407-13-293.
    CrossRef  |  Direct Link  |  
  81. Karan-Djurasevic, T., V. Palibrk, B. Zukic, V. Spasovski and I. Glumac et al., 2013. Expression of BCL2L12 in chronic lymphocytic leukemia patients: Association with clinical and molecular prognostic markers. Med. Oncol., Vol. 30. 10.1007/s12032-012-0405-7.
    CrossRef  |  Direct Link  |  
  82. Geomela, P.A., C.K. Kontos, I. Yiotakis and A. Scorilas, 2013. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma. J. Oral Pathol. Med., 42: 154-161.
    CrossRef  |  Direct Link  |  
  83. Florou, D., I.N. Papadopoulos, E.G. Fragoulis and A. Scorilas, 2013. L-Dopa Decarboxylase (DDC) constitutes an emerging biomarker in predicting patients' survival with stomach adenocarcinomas. J. Cancer Res. Clin. Oncol., 139: 297-306.
    CrossRef  |  Direct Link  |  
  84. Florou, D., C. Patsis, A. Ardavanis and A. Scorilas, 2013. Effect of doxorubicin, oxaliplatin and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells. Cancer Biol. Ther., 14: 587-596.
    CrossRef  |  Direct Link  |  
  85. Devetzi, M., T. Trangas, A. Scorilas, D. Xynopoulos and M. Talieri, 2013. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7 & KLK14) in colon cancer. Thromb. Haemost., 109: 716-725.
    CrossRef  |  Direct Link  |  
  86. Avgeris, M., K. Stravodimos, E.G. Fragoulis and A. Scorilas, 2013. The loss of the tumour-suppressor miR-145 results in the shorter disease-free survival of prostate cancer patients. Br. J. Cancer, 108: 2573-2581.
    CrossRef  |  Direct Link  |  
  87. Alexopoulou, D.K., I.N. Papadopoulos and A. Scorilas, 2013. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. Clin. Biochem., 46: 1453-1461.
    CrossRef  |  Direct Link  |  
  88. Tzifi, F., C. Economopoulou, D. Gourgiotis, A. Ardavanis, S. Papageorgiou and A. Scorilas, 2012. The role of bcl2 family of apoptosis regulator proteins in acute and chronic leukemias. Adv. Hematol., 10.1155/2012/524308.
    CrossRef  |  Direct Link  |  
  89. Thomadaki, H., K.V. Floros, S. Pavlovic, N. Tosic, D. Gourgiotis, M. Colovic and A. Scorilas, 2012. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia. Clin. Biochem., 45: 1362-1367.
    CrossRef  |  Direct Link  |  
  90. Thanopoulou, E., G. Kotzamanis, I.S. Pateras, N. Ziras and A. Papalambros et al., 2012. The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer. Tumor Biol., 33: 1429-1436.
    CrossRef  |  Direct Link  |  
  91. Talieri, M., M. Zoma, M. Devetzi, A. Scorilas and A. Ardavanis, 2012. Kallikrein-related peptidase 6 (KLK6) gene expression in intracranial tumors. Tumor Biol., 33: 1375-1383.
    CrossRef  |  Direct Link  |  
  92. Talieri, M., M. Devetzi, A. Scorilas, E. Pappa, N. Tsapralis, I. Missitzis and A. Ardavanis, 2012. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact. Tumor Biol., 33: 1075-1084.
    CrossRef  |  Direct Link  |  
  93. Petraki, C., Y.M. Youssef, W. Dubinski, Z. Lichner and A. Scorilas et al., 2012. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumor Biol., 33: 1209-1214.
    CrossRef  |  Direct Link  |  
  94. Petraki, C., W. Dubinski, A. Scorilas, C. Saleh and M.D. Pasic et al., 2012. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Pathol.-Res. Pract., 208: 104-108.
    CrossRef  |  Direct Link  |  
  95. Patsis, C., V. Glyka, I. Yiotakis, E.G. Fragoulis and A. Scorilas, 2012. L-DOPA Decarboxylase (DDC) expression status as a novel molecular tumor marker for diagnostic and prognostic purposes in laryngeal cancer. Transl. Oncol., 5: 288-296.
    CrossRef  |  Direct Link  |  
  96. Patsis, C., I. Yiotakis and A. Scorilas, 2012. Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer. Clin. Biochem., 45: 623-630.
    CrossRef  |  Direct Link  |  
  97. Koutalellis, G., K. Stravodimos, M. Avgeris, K. Mavridis, A. Scorilas, A. Lazaris and C. Constantinides, 2012. L-Dopa Decarboxylase (DDC) gene expression is related to outcome in patients with prostate cancer. BJU Int., 110: E267-E273.
    CrossRef  |  Direct Link  |  
  98. Korbakis, D. and A. Scorilas, 2012. Quantitative expression analysis of the apoptosis-related genes BCL2, BAX and BCL2L12 in gastric adenocarcinoma cells following treatment with the anticancer drugs cisplatin, etoposide and taxol. Tumor Biol., 33: 865-875.
    CrossRef  |  Direct Link  |  
  99. Kontos, C.K. and A. Scorilas, 2012. Molecular cloning of novel alternatively spliced variants of BCL2L12, a new member of the BCL2 gene family and their expression analysis in cancer cells. Gene, 505: 153-166.
    CrossRef  |  Direct Link  |  
  100. Kontos, C.K. and A. Scorilas, 2012. Kallikrein-related peptidases (KLKs): A gene family of novel cancer biomarkers. Clin. Chem. Lab. Med., 50: 1877-1891.
    CrossRef  |  Direct Link  |  
  101. Iakovlev, V.V., M. Gabril, W. Dubinski, A. Scorilas and Y.M. Youssef et al., 2012. Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: An automated image analysis study. Lab. Invest., 92: 46-56.
    CrossRef  |  Direct Link  |  
  102. Geomela, P.A., C.K. Kontos, I. Yiotakis, E.G. Fragoulis and A. Scorilas, 2012. L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: A retrospective cohort study. BMC Cancer, Vol. 12. 10.1186/1471-2407-12-484.
    CrossRef  |  Direct Link  |  
  103. Florou, D., K. Mavridis and A. Scorilas, 2012. The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents. Tumor Biol., 33: 2069-2078.
    CrossRef  |  Direct Link  |  
  104. Faragalla, H., Y.M. Youssef, A. Scorilas, B. Khalil and N.M. White et al., 2012. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J. Mol. Diagn., 14: 385-392.
    CrossRef  |  Direct Link  |  
  105. Evangelou, I., C. Petraki, P. Msaouel, A. Scorilas and E. Sdrolia et al., 2012. Immunohistochemical expression of somatostatin receptor subtypes 2 and 5 in colorectal cancer. Eur. J. Clin. Invest., 42: 777-783.
    CrossRef  |  Direct Link  |  
  106. Dubinski, W., M. Gabril, V.V. Iakovlev, A. Scorilas and Y.M. Youssef et al., 2012. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis. Hum. Pathol., 43: 1037-1043.
    CrossRef  |  Direct Link  |  
  107. Avgeris, M., K. Mavridis and A. Scorilas, 2012. Kallikrein-related peptidases in prostate, breast and ovarian cancers: from pathobiology to clinical relevance. Biol. Chem., 393: 301-317.
  108. Xinopoulos, D., S.P. Bassioukas, D. Kypreos, D. Korkolis and A. Scorilas et al., 2011. Pancreatic duct guidewire placement for biliary cannulation in a single-session therapeutic ERCP. World J. Gastroenterol., 17: 1989-1995.
    CrossRef  |  Direct Link  |  
  109. Xinopoulos, D., D. Kypreos, S.P. Bassioukas, D. Korkolis and K. Mavridis et al., 2011. Comparative study of balloon and metal olive dilators for endoscopic management of benign anastomotic rectal strictures: Clinical and cost-effectiveness outcomes. Surg. Endosc., 25: 756-763.
    CrossRef  |  Direct Link  |  
  110. Thomadaki, H., A. Lymberopoulou-Karaliota, A. Maniatakou and A. Scorilas, 2011. Synthesis, spectroscopic study and anticancer activity of a water-soluble Nb(V) peroxo complex. J. Inorg. Biochem., 105: 155-163.
    CrossRef  |  Direct Link  |  
  111. Talieri, M., M. Devetzi, A. Scorilas, P. Prezas, A. Ardavanis, A. Apostolaki and A. Karameris, 2011. Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: Association with kallikrein-related peptidase 7 expression. Anticancer Res., 31: 3093-3100.
    Direct Link  |  
  112. Talieri, M., D.K. Alexopoulou, A. Scorilas, D. Kypraios and N. Arnogiannaki et al., 2011. Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumor Biol., 32: 737-744.
    CrossRef  |  Direct Link  |  
  113. Papageorgiou, S.G., C.K. Kontos, V. Pappa, H. Thomadaki and F. Kontsioti et al., 2011. The novel member of the BCL2 gene family, BCL2L12, is substantially elevated in chronic lymphocytic leukemia patients, supporting its value as a significant biomarker. Oncologist, 16: 1280-1291.
    CrossRef  |  Direct Link  |  
  114. Papachristopoulou, G., M. Avgeris, A. Charlaftis and A. Scorilas, 2011. Quantitative expression analysis and study of the novel human kallikrein-related peptidase 14 gene (KLK14) in malignant and benign breast tissues. Thromb. Haemost., 105: 131-137.
    CrossRef  |  Direct Link  |  
  115. Mathioudaki, K., A. Scorilas, A. Ardavanis, P. Lymberi and E. Tsiambas et al., 2011. Clinical evaluation of PRMT1 gene expression in breast cancer. Tumor Biol., 32: 575-582.
    CrossRef  |  Direct Link  |  
  116. Jamaspishvili, T., A. Scorilas, M. Kral, I. Khomeriki, D. Kurfurstova, Z. Kolar and J. Bouchal, 2011. Immunohistochemical localization and analysis of kallikrein-related peptidase 7 and 11 expression in paired cancer and benign foci in prostate cancer patients. Neoplasma, 58: 298-303.
    PubMed  |  Direct Link  |  
  117. Fendri, A., C.K. Kontos, A. Khabir, R. Mokdad-Gargouri and A. Scorilas, 2011. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma. Mol. Med., 17: 163-171.
    CrossRef  |  Direct Link  |  
  118. Avgeris, M., K. Stravodimos and A. Scorilas, 2011. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: Quantitative expression analysis and evaluation of its clinical significance. Prostate, 71: 1780-1789.
    CrossRef  |  Direct Link  |  
  119. Avgeris, M., G. Papachristopoulou, A. Polychronis and A. Scorilas, 2011. Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: A biomarker for the differential diagnosis of breast lesions. Clin. Proteomics, Vol. 8. 10.1186/1559-0275-8-5.
    CrossRef  |  Direct Link  |  
  120. Mavridis, K., M. Talieri and A. Scorilas, 2010. KLK5 gene expression is severely upregulated in androgen-independent prostate cancer cells after treatment with the chemotherapeutic agents docetaxel and mitoxantrone. Biol. Chem., 391: 467-474.
    CrossRef  |  Direct Link  |  
  121. Mavridis, K., M. Avgeris, G. Koutalellis, K. Stravodimos and A. Scorilas, 2010. Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia. Cancer Sci., 101: 693-699.
    CrossRef  |  Direct Link  |  
  122. Mavridis, K. and A. Scorilas, 2010. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. Fut. Oncol., 6: 269-285.
    CrossRef  |  Direct Link  |  
  123. Kontos, C.K., I.N. Papadopoulos, E.G. Fragoulis and A. Scorilas, 2010. Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma. Br. J. Cancer, 102: 1384-1390.
    CrossRef  |  Direct Link  |  
  124. Konstantoudakis, G., D. Florou, K. Mavridis, I.N. Papadopoulos and A. Scorilas, 2010. Kallikrein-related peptidase 13 (KLK13) gene expressional status contributes significantly in the prognosis of primary gastric carcinomas. Clin. Biochem., 43: 1205-1211.
    CrossRef  |  Direct Link  |  
  125. Florou, D., I.N. Papadopoulos and A. Scorilas, 2010. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer. Biochem. Biophys. Res. Commun., 391: 214-218.
    CrossRef  |  Direct Link  |  
  126. Fendri, A., C.K. Kontos, A. Khabir, R. Mokdad-Gargouri, A. Ardavanis and A. Scorilas, 2010. Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: An unfavorable and independent prognostic factor. Tumor Biol., 31: 391-399.
    CrossRef  |  Direct Link  |  
  127. Dorn, J., N. Harbeck, R. Kates, A. Gkazepis and A. Scorilas et al., 2010. Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer. Ann. Oncol., 22: 877-883.
    CrossRef  |  Direct Link  |  
  128. Chow, TF.F., M. Mankaruos, A. Scorilas, Y. Youssef and A. Girgis et al., 2010. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J. Urol., 183: 743-751.
    CrossRef  |  Direct Link  |  
  129. Avgeris, M., K. Mavridis and A. Scorilas, 2010. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies. Biol. Chem., 391: 505-511.
    CrossRef  |  Direct Link  |  
  130. Thomadaki, H., K.V. Floros and A. Scorilas, 2009. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12. Ann. N. Y. Acad. Sci., 1171: 276-283.
    CrossRef  |  Direct Link  |  
  131. Thomadaki, H., K. Mavridis, M. Talieri and A. Scorilas, 2009. Treatment of PC3 prostate cancer cells with mitoxantrone, etoposide, doxorubicin and carboplatin induces distinct alterations in the expression of kallikreins 5 and 11. Thromb. Haemost., 101: 373-380.
    CrossRef  |  Direct Link  |  
  132. Theophanous, E., C. Petraki, A. Scorilas, V. Komborozos and G. Veloudis et al., 2009. The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer. Mol. Med., 15: 242-247.
    CrossRef  |  Direct Link  |  
  133. Talieri, M., L. Li, Y. Zheng, D.K. Alexopoulou and A. Soosaipillai et al., 2009. The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer. Br. J. Cancer, 100: 1659-1665.
    CrossRef  |  Direct Link  |  
  134. Talieri, M., K. Mathioudaki, P. Prezas, D.K. Alexopoulou and E.P. Diamandis et al., 2009. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer. Thromb. Haemost., 102: 741-747.
    PubMed  |  
  135. Siu, K.W.M., L.V. DeSouza, A. Scorilas, A.D. Romaschin and R.J. Honey et al., 2009. Differential protein expressions in renal cell carcinoma: New biomarker discovery by mass spectrometry. J. Proteome Res., 8: 3797-3807.
    CrossRef  |  Direct Link  |  
  136. Psyrri, A., S. Papageorgiou, E. Liakata, A. Scorilas and D. Rontogianni et al., 2009. Phosphatidylinositol 3′-kinase catalytic subunit α gene amplification contributes to the pathogenesis of mantle cell lymphoma. Clin. Cancer Res., 15: 5724-5732.
    CrossRef  |  Direct Link  |  
  137. Papadokostopoulou, A., K. Mathioudaki, A. Scorilas, D. Xynopoulos, A. Ardavanis, E. Kouroumalis and M. Talieri, 2009. Colon cancer and protein arginine methyltransferase 1 gene expression. Anticancer Res., 29: 1361-1366.
    Direct Link  |  
  138. Papachristopoulou, G., M. Avgeris and A. Scorilas, 2009. Expression analysis and study of KLK4 in benign and malignant breast tumours. Thromb. Haemost., 101: 381-387.
    CrossRef  |  Direct Link  |  
  139. Kountourakis, P., A. Psyrri, A. Scorilas, S. Markakis and D. Kowalski et al., 2009. Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis. Thromb. Haemost., 101: 541-546.
    CrossRef  |  Direct Link  |  
  140. Korbakis, D., A.K. Gregorakis and A. Scorilas, 2009. Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: An independent cancer biomarker. Clin. Chem., 55: 904-913.
    CrossRef  |  Direct Link  |  
  141. Korbakis, D. and A. Scorilas, 2009. Treatment of gastric cancer cells with 5-fluorouracil/leucovorin and irinotecan induces distinct alterations in the mRNA expression of the apoptosis-related genes, including the novel gene BCL2L12. Tumor Biol., 30: 100-107.
    CrossRef  |  Direct Link  |  
  142. Emami, N., A. Scorilas, A. Soosaipillai, T. Earle, B. Mullen and E.P. Diamandis, 2009. Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: Their relation to sperm motility. Biol. Chem., 390: 921-929.
    CrossRef  |  Direct Link  |  
  143. Devetzi, M., A. Scorilas, E. Tsiambas, M. Sameni, S. Fotiou, B.F. Sloane and M. Talieri, 2009. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker. Gynecol. Oncol., 112: 531-536.
    CrossRef  |  Direct Link  |  
  144. Thomadaki, H., C.M. Tsiapalis and A. Scorilas, 2008. The effect of the polyadenylation inhibitor cordycepin on human Molt-4 and Daudi leukaemia and lymphoma cell lines. Cancer Chemother. Pharmacol., 61: 703-711.
    CrossRef  |  Direct Link  |  
  145. Thomadaki, H., A. Scorilas, C.M. Tsiapalis and M. Havredaki, 2008. The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: Implication of polyadenylation in a cell type specific manner. Cancer Chemother. Pharmacol., 61: 251-265.
    CrossRef  |  Direct Link  |  
  146. Thomadaki, H., A. Karaliota, C. Litos and A. Scorilas, 2008. Enhanced concentration-dependent cytotoxic effect of the dinuclear copper(II) complex of L-carnitine [Cu2(L-carnitine)2Cl2(H2O)2]Cl2, compared to L-carnitine or copper chloride dihydrate, in human leukemic cell lines. J. Med. Chem., 51: 3713-3719.
    CrossRef  |  Direct Link  |  
  147. Thomadaki, H. and A. Scorilas, 2008. Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs. Connective Tiss. Res., 49: 261-264.
    CrossRef  |  Direct Link  |  
  148. Thomadaki, H. and A. Scorilas, 2008. Molecular profile of breast versus ovarian cancer cells in response to treatment with the anticancer drugs cisplatin, carboplatin, doxorubicin, etoposide and taxol. Biol. Chem., 389: 1427-1434.
    CrossRef  |  Direct Link  |  
  149. Psyrri, A., P. Kountourakis, A. Scorilas, S. Markakis and R. Camp et al., 2008. Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression. Ann. Oncol., 19: 1271-1277.
    CrossRef  |  Direct Link  |  
  150. Pampalakis, G., A. Scorilas and G. Sotiropoulou, 2008. Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer. Clin. Biochem., 41: 591-597.
    CrossRef  |  Direct Link  |  
  151. Mathioudaki, K., A. Papadokostopoulou, A. Scorilas, D. Xynopoulos, N. Agnanti and M. Talieri, 2008. The PRMT1 gene expression pattern in colon cancer. Br. J. Cancer, 99: 2094-2099.
    CrossRef  |  Direct Link  |  
  152. Kountourakis, P., A. Psyrri, A. Scorilas, R. Camp and S. Markakis et al., 2008. Prognostic value of kallikrein-related peptidase 6 protein expression levels in advanced ovarian cancer evaluated by Automated Quantitative Analysis (AQUA). Cancer Sci., 99: 2224-2229.
    CrossRef  |  Direct Link  |  
  153. Kontos, C.K., I.N. Papadopoulos and A. Scorilas, 2008. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer. Biol. Chem., 389: 1467-1475.
    CrossRef  |  Direct Link  |  
  154. Gregorakis, A.K., S. Stefanakis, D. Malovrouvas, K. Petraki, D. Gourgiotis and A. Scorilas, 2008. Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy. Prostate, 68: 759-765.
    CrossRef  |  Direct Link  |  
  155. Garoufali, A., F. Kyriakou, P. Kountourakis, I. Yioti and S. Malliou et al., 2008. Extracellular domain of HER2: A useful marker for the initial workup and follow-up of HER2-positive breast cancer. J. Balkan Union Oncol., 13: 409-413.
    PubMed  |  Direct Link  |  
  156. Avgeris, M., G. Koutalellis, E.G. Fragoulis and A. Scorilas, 2008. Expression analysis and clinical utility of L-Dopa Decarboxylase (DDC) in prostate cancer. Clin. Biochem., 41: 1140-1149.
    CrossRef  |  Direct Link  |  
  157. Ardavanis, A., S. Koumna, I. Fragos, S. Malliou and F. Kyriakou et al., 2008. Erlotinib monotherapy in patients with advanced non-small cell lung cancer: An effective approach with low toxicity. Anticancer Res., 28: 2409-2415.
    Direct Link  |  
  158. Ardavanis, A., P. Kountourakis, F. Kyriakou, S. Malliou and I. Mantzaris et al., 2008. Trastuzumab plus paclitaxel or docetaxel in HER-2-negative/HER-2 ECD-positive anthracycline- and taxane-refractory advanced breast cancer. Oncologist, 13: 361-369.
    CrossRef  |  Direct Link  |  
  159. Zheng, Y., D. Katsaros, S.J. Shan, I.R. de la Longrais and M. Porpiglia et al., 2007. A multiparametric panel for ovarian cancer diagnosis, prognosis and response to chemotherapy. Clin. Cancer Res., 13: 6984-6992.
    CrossRef  |  Direct Link  |  
  160. Thomadaki, H., M. Talieri and A. Scorilas, 2007. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer. Cancer Lett., 247: 48-55.
    CrossRef  |  Direct Link  |  
  161. Thomadaki, H., A. Karaliota, C. Litos and A. Scorilas, 2007. Enhanced antileukemic activity of the novel complex 2,5-dihydroxybenzoate molybdenum(VI) against 2,5-dihydroxybenzoate, polyoxometalate of Mo(VI) and tetraphenylphosphonium in the human HL-60 and K562 leukemic cell lines. J. Med. Chem., 50: 1316-1321.
    CrossRef  |  Direct Link  |  
  162. Thomadaki, H. and A. Scorilas, 2007. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. Ann. N. Y. Acad. Sci., 1095: 35-44.
    CrossRef  |  Direct Link  |  
  163. Simon, I., D. Katsaros, I.R. de la Longrais, M. Massobrio and A. Scorilas et al., 2007. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression. Gynecol. Oncol., 106: 334-341.
    CrossRef  |  Direct Link  |  
  164. Shan, S.J.C., A. Scorilas, D. Katsaros and E.P. Diamandis, 2007. Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: Clinical and mechanistic aspects. Br. J. Cancer, 96: 362-372.
    CrossRef  |  Direct Link  |  
  165. Revelos, K., C. Petraki, A. Scorilas, S. Stefanakis and D. Malovrouvas et al., 2007. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer. Anticancer Res., 27: 3651-3660.
    Direct Link  |  
  166. Katsarou, M.E., H. Thomadaki, N. Katsaros and A. Scorilas, 2007. Effect of bleomycin and cisplatin on the expression profile of SRA1, a novel member of pre-mRNA splicing factors, in HL-60 human promyelocytic leukemia cells. Biol. Chem., 388: 773-778.
    CrossRef  |  Direct Link  |  
  167. Efthimiadou, E.K., H. Thomadaki, Y. Sanakis, C.P. Raptopoulou and N. Katsaros et al., 2007. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine. J. Inorg. Biochem., 101: 64-73.
    CrossRef  |  Direct Link  |  
  168. Dorn, J., M. Schmitt, R. Kates, B. Schmalfeldt and M. Kiechle et al., 2007. Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients. Clin. Cancer Res., 13: 1742-1748.
    CrossRef  |  Direct Link  |  
  169. Thomadaki, H., M. Talieri and A. Scorilas, 2006. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biol. Chem., 387: 1081-1086.
    CrossRef  |  Direct Link  |  
  170. Thomadaki, H. and A. Scorilas, 2006. :BCL2 family of apoptosis-related genes: Functions and clinical implications in cancer. Crit. Rev. Clin. Lab. Sci., 43: 1-67.
    CrossRef  |  Direct Link  |  
  171. Slagter, M.H., L.J. Gooren, W. de Ronde, A. Soosaipillai and A. Scorilas et al., 2006. Serum and urine tissue kallikrein concentrations in male-to-female transsexuals treated with antiandrogens and estrogens. Clin. Chem., 52: 1356-1365.
    CrossRef  |  Direct Link  |  
  172. Slagter, M.H., L.J. Gooren, A. Scorilas, C.D. Petraki and E.P. Diamandis, 2006. Effects of long-term androgen administration on breast tissue of female-to-male transsexuals. J. Histochem. Cytochem., 54: 905-910.
    CrossRef  |  Direct Link  |  
  173. Slagter, M.H., A. Scorilas, L.J. Gooren, W. de Ronde and A. Soosaipillai et al., 2006. Effect of testosterone administration on serum and urine kallikrein concentrations in female-to-male transsexuals. Clin. Chem., 52: 1546-1551.
    CrossRef  |  Direct Link  |  
  174. Shan, S.J., A. Scorilas, D. Katsaros, I.R. de la Longrais, M. Massobrio and E.P. Diamandis, 2006. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols. Clin. Chem., 52: 1879-1886.
    CrossRef  |  Direct Link  |  
  175. Scorilas, A. and A.K. Gregorakis, 2006. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy. Biol. Chem., 387: 789-793.
    CrossRef  |  Direct Link  |  
  176. Prezas, P., A. Scorilas, C. Yfanti, P. Viktorov, N. Agnanti, E. Diamandis and M. Talieri, 2006. The role of human tissue kallikreins 7 and 8 in intracranial malignancies. Biol. Chem., 387: 1607-1612.
    CrossRef  |  Direct Link  |  
  177. Oikonomopoulou, K., A. Scorilas, I.P. Michael, L. Grass and A. Soosaipillai et al., 2006. Kallikreins as markers of disseminated tumour cells in ovarian cancer-a pilot study. Tumor Biol., 27: 104-114.
    CrossRef  |  Direct Link  |  
  178. Lundwall, Å., V. Band, M. Blaber, J.A. Clements and Y. Courty et al., 2006. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. Biol. Chem., 387: 637-641.
    CrossRef  |  Direct Link  |  
  179. Leoutsakou, T., M. Talieri and A. Scorilas, 2006. Prognostic significance of the expression of SR-A1, encoding a novel SR-related CTD-associated factor, in breast cancer. Biol. Chem., 387: 1613-1618.
    CrossRef  |  Direct Link  |  
  180. Leoutsakou, T., M. Talieri and A. Scorilas, 2006. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer. Biochem. Biophys. Res. Commun., 344: 667-674.
    CrossRef  |  Direct Link  |  
  181. Floros, K.V., M. Talieri and A. Scorilas, 2006. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells. Biol. Chem., 387: 1629-1633.
    CrossRef  |  Direct Link  |  
  182. Floros, K.V., H. Thomadaki, D. Florou, M. Talieri and A. Scorilas, 2006. Alterations in mRNA expression of apoptosisrelated genes BCL2, BAX, FAS, Caspase-3 and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide. Ann. N. Y. Acad. Sci., 1090: 89-97.
    CrossRef  |  Direct Link  |  
  183. Borgono, C.A., T. Kishi, A. Scorilas, N. Harbeck and J. Dorn et al., 2006. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin. Cancer Res., 12: 1487-1493.
    CrossRef  |  Direct Link  |  
  184. Ardavanis, A., A. Scorilas, D. Tryfonopoulos, G. Orphanos and I. Missitzis et al., 2006. Multidisciplinary therapy of locally far-advanced or inflammatory breast cancer with fixed perioperative sequence of epirubicin, vinorelbine and fluorouracil chemotherapy, surgery and radiotherapy: Long-term results. Oncologist, 11: 563-573.
    CrossRef  |  Direct Link  |  
  185. Agiamarnioti, K., T. Triantis, K. Papadopoulos and A. Scorilas, 2006. 10-(2-Biotinyloxyethyl)-9-acridone: A novel fluorescent label for (strept) avidin-biotin based assays. J. Photochem. Photobiol. A: Chem., 181: 126-131.
    CrossRef  |  Direct Link  |  
  186. Yousef, G.M., C.V. Obiezu, L.Y. Luo, A. Magklara and C.A. Borgono et al., 2005. Human tissue kallikreins: From gene structure to function and clinical applications. Adv. Clin. Chem., 39: 11-79.
    CrossRef  |  Direct Link  |  
  187. Yannopoulos, A., E. Dimitriadis, A. Scorilas, T. Trangas, E. Markakis and M. Talieri, 2005. mRNA quantification and clinical evaluation of telomerase reverse transcriptase subunit (hTERT) in intracranial tumours of patients in the island of Crete. Br. J. Cancer, 93: 152-158.
    CrossRef  |  Direct Link  |  
  188. Thomadaki, H., C.M. Tsiapalis and A. Scorilas, 2005. Polyadenylate polymerase modulations in human epithelioid cervix and breast cancer cell lines, treated with etoposide or cordycepin, follow cell cycle rather than apoptosis induction. Biol. Chem., 386: 471-480.
    CrossRef  |  Direct Link  |  
  189. Stavropoulou, P., A.K. Gregorakis, M. Plebani and A. Scorilas, 2005. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer. Clin. Chim. Acta, 357: 190-195.
    CrossRef  |  Direct Link  |  
  190. Scorilas, A., K. Agiamarnioti and K. Papadopoulos, 2005. Novel biotinylated acridinium derivatives: New reagents for fluorescence immunoassays and proteomics. Clin. Chim. Acta, 357: 159-167.
    CrossRef  |  Direct Link  |  
  191. Revelos, K., C. Petraki, A. Gregorakis, A. Scorilas, P. Papanastasiou, R. Tenta and M. Koutsilieris, 2005. p27kip1 and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. In vivo, 19: 911-920.
    Direct Link  |  
  192. Revelos, K., C. Petraki, A. Gregorakis, A. Scorilas, P. Papanastasiou and M. Koutsilieris, 2005. Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy. Anticancer Res., 25: 3123-3133.
    Direct Link  |  
  193. Katsarou, M.E., A. Papakyriakou, N. Katsaros and A. Scorilas, 2005. Expression of the C-terminal domain of novel human SR-A1 protein: Interaction with the CTD domain of RNA polymerase II. Biochem. Biophys. Res. Commun., 334: 61-68.
    CrossRef  |  Direct Link  |  
  194. Gregorakis, A.K., D. Malovrouvas, S. Stefanakis, K. Petraki and A. Scorilas, 2005. Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy. Clin. Chim. Acta, 357: 196-201.
    CrossRef  |  Direct Link  |  
  195. Ardavanis, A., D. Tryfonopoulos, G. Orfanos, M. Karamouzis, A. Scorilas, A. Alexopoulos and G. Rigatos, 2005. Safety and efficacy of trastuzumab every 3 weeks combined with cytotoxic chemotherapy in patients with HER2-positive recurrent breast cancer: Findings from a case series. Oncol. Res. Treat., 28: 558-564.
    CrossRef  |  Direct Link  |  
  196. Talieri, M., S. Papadopoulou, A. Scorilas, D. Xynopoulos and N. Arnogianaki et al., 2004. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma. Cancer Lett., 205: 97-106.
    CrossRef  |  Direct Link  |  
  197. Talieri, M., E.P. Diamandis, D. Gourgiotis, K. Mathioudaki and A. Scorilas, 2004. Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: A new potential biomarker for prognosis of breast carcinoma. Thromb. Haemost., 91: 180-186.
    CrossRef  |  Direct Link  |  
  198. Stephan, C., G.M. Yousef, A. Scorilas, K. Jung and M. Jung et al., 2004. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J. Urol., 171: 187-191.
    CrossRef  |  Direct Link  |  
  199. Scorilas, A., C.A. Borgono, N. Harbeck, J. Dorn, B. Schmalfeldt, M. Schmitt and E.P. Diamandis, 2004. Human kallikrein 13 protein in ovarian cancer cytosols: A new favorable prognostic marker. J. Clin. Oncol., 22: 678-685.
    CrossRef  |  PubMed  |  Direct Link  |  
  200. Mathioudaki, K., T. Leotsakou, A. Papadokostopoulou, E. Paraskevas, A. Ardavanis, M. Talieri and A. Scorilas, 2004. SR-A1, a member of the human pre-mRNA splicing factor family and its expression in colon cancer progression. Biol. Chem., 385: 785-790.
    CrossRef  |  Direct Link  |  
  201. Mathioudaki, K., A. Scorilas, A. Papadokostopoulou, D. Xynopoulos, N. Arnogianaki, N. Agnanti and M. Talieri, 2004. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. Biol. Chem., 385: 779-783.
    CrossRef  |  Direct Link  |  
  202. Floros, K.V., H. Thomadaki, N. Katsaros, M. Talieri and A. Scorilas, 2004. mRNA expression analysis of a variety of apoptosis-related genes, including the novel gene of the BCL2-family, BCL2L12, in HL-60 leukemia cells after treatment with carboplatin and doxorubicin. Biol. Chem., 385: 1099-1103.
    CrossRef  |  Direct Link  |  
  203. Diamandis, E.P., C.A. Borgono, A. Scorilas, N. Harbeck, J. Dorn and M. Schmitt, 2004. Human kallikrein 11: An indicator of favorable prognosis in ovarian cancer patients. Clin. Biochem., 37: 823-829.
    CrossRef  |  Direct Link  |  
  204. Diamandis, E.P., A. Scorilas, T. Kishi, K. Blennow and L.Y. Luo et al., 2004. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia. Clin. Biochem., 37: 230-237.
    CrossRef  |  Direct Link  |  
  205. Yousef, G.M., S. Fracchioli, A. Scorilas, C.A. Borgono and L. Iskander et al., 2003. Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer. Am. J. Clin. Pathol., 119: 346-355.
    CrossRef  |  Direct Link  |  
  206. Yousef, G.M., M.E. Polymeris, L. Grass, A. Soosaipillai and P.C. Chan et al., 2003. Human kallikrein 5: A potential novel serum biomarker for breast and ovarian cancer. Cancer Res., 63: 3958-3965.
    Direct Link  |  
  207. Yousef, G.M., M.E. Polymeris, G.M. Yacoub and A. Scorilas et al., 2003. Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res., 63: 2223-2227.
    Direct Link  |  
  208. Yousef, G.M., C. Stephan, A. Scorilas, M.A. Ellatif and K. Jung et al., 2003. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues. Prostate, 56: 287-292.
    CrossRef  |  Direct Link  |  
  209. Yousef, G.M., A. Scorilas, T. Nakamura, M.A. Ellatif and R. Ponzone et al., 2003. The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer. Breast Cancer Res. Treat., 78: 149-158.
    CrossRef  |  Direct Link  |  
  210. Yousef, G.M., A. Scorilas, D. Katsaros, S. Fracchioli and L. Iskander et al., 2003. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. J. Clin. Oncol., 21: 3119-3126.
    CrossRef  |  PubMed  |  Direct Link  |  
  211. Talieri, M., E.P. Diamandis, N. Katsaros, D. Gourgiotis and A. Scorilas, 2003. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors. Thromb. Haemost., 89: 1081-1088.
    PubMed  |  
  212. Stephan, C., G.M. Yousef, A. Scorilas, K. Jung and M. Jung et al., 2003. Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J. Urol., 169: 361-364.
    CrossRef  |  Direct Link  |  
  213. Scorilas, A., P.M. Chiang, D. Katsaros, G.M. Yousef and E.P. Diamandis, 2003. Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors. Gene, 310: 79-89.
    CrossRef  |  Direct Link  |  
  214. Scorilas, A., M. Plebani, S. Mazza, D. Basso and A.R. Soosaipillai et al., 2003. Serum human glandular kallikrein (hK2) and Insulin-like Growth Factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA. Prostate, 54: 220-229.
    CrossRef  |  Direct Link  |  
  215. Nakamura, T., C. Stephan, A. Scorilas, G.M. Yousef, K. Jung and E.P. Diamandis, 2003. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. Urology, 61: 1042-1046.
    CrossRef  |  Direct Link  |  
  216. Nakamura, T., A. Scorilas, C. Stephan, K. Jung, A.R. Soosaipillai and E.P. Diamandis, 2003. The usefulness of serum human kallikrein 11 for discriminating between prostate cancer and benign prostatic hyperplasia. Cancer Res., 63: 6543-6546.
    Direct Link  |  
  217. Nakamura, T., A. Scorilas, C. Stephan, G.M. Yousef, G. Kristiansen, K. Jung and E.P. Diamandis, 2003. Quantitative analysis of Macrophage Inhibitory Cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br. J. Cancer, 88: 1101-1104.
    CrossRef  |  PubMed  |  Direct Link  |  
  218. Kyriakopoulou, L.G., G.M. Yousef, A. Scorilas, D. Katsaros, M. Massobrio, S. Fracchioli and E.P. Diamandis, 2003. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. Clin. Biochem., 36: 135-143.
    CrossRef  |  Direct Link  |  
  219. Kishi, T., L. Grass, A. Soosaipillai, A. Scorilas and N. Harbeck et al., 2003. Human kallikrein 8, a novel biomarker for ovarian carcinoma. Cancer Res., 63: 2771-2774.
    Direct Link  |  
  220. Floros, K.V., H. Thomadaki, G. Lallas, N. Katsaros, M. Talieri and A. Scorilas, 2003. Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells. Ann. N. Y. Acad. Sci., 1010: 153-158.
    CrossRef  |  Direct Link  |  
  221. Diamandis, E.P., C.A. Borgono, A. Scorilas, G.M. Yousef and N. Harbeck et al., 2003. Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis. Tumor Biol., 24: 299-309.
    CrossRef  |  Direct Link  |  
  222. Diamandis, E.P., A. Scorilas, S. Fracchioli, M. van Gramberen and H. de Bruijn et al., 2003. Human kallikrein 6 (hK6): A new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol., 21: 1035-1043.
    CrossRef  |  PubMed  |  Direct Link  |  
  223. Borgono, C.A., S. Fracchioli, G.M. Yousef, I.A.R. de la Longrais and L.Y. Luo et al., 2003. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. Int. J. Cancer, 106: 605-610.
    CrossRef  |  Direct Link  |  
  224. Zarghooni, M., A. Soosaipillai, L. Grass, A. Scorilas, N. Mirazimi and E.P. Diamandis, 2002. Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Clin. Biochem., 35: 225-231.
    CrossRef  |  Direct Link  |  
  225. Yousef, G.M., C.V. Obiezu, K. Jung, C. Stephan, A. Scorilas and E.P. Diamandis, 2002. Differential expression of Kallikrein gene 5 in cancerous and normal testicular tissues. Urology, 60: 714-718.
    CrossRef  |  Direct Link  |  
  226. Yousef, G.M., C.A. Borgono, A. Scorilas, R. Ponzone and N. Biglia et al., 2002. Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis. Br. J. Cancer, 87: 1287-1293.
    CrossRef  |  Direct Link  |  
  227. Yousef, G.M., A. Scorilas, L.G. Kyriakopoulou, L. Rendl and M. Diamandis et al., 2002. Human kallikrein gene 5 (KLK5) expression by quantitative PCR: An independent indicator of poor prognosis in breast cancer. Clin. Chem., 48: 1241-1250.
    Direct Link  |  
  228. Yousef, G.M., A. Scorilas, A. Magklara, N. Memari and R. Ponzone et al., 2002. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer. Br. J. Cancer, 87: 1294-3000.
    CrossRef  |  Direct Link  |  
  229. Yousef, G.M., A. Scorilas, A. Chang, L. Rendl, M. Diamandis, K. Jung and E.P. Diamandis, 2002. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues. Prostate, 51: 126-132.
    CrossRef  |  Direct Link  |  
  230. Scorilas, A., S. Fotiou, E. Tsiambas, J. Yotis and F. Kotsiandri et al., 2002. Determination of cathepsin B expression may offer additional prognostic information for ovarian cancer patients. Biol. Chem., 383: 1297-1303.
    CrossRef  |  Direct Link  |  
  231. Scorilas, A., M.A. Levesque, L.K. Ashworth and E.P. Diamandis, 2002. Cloning, physical mapping and structural characterization of the human αA-adaptin gene. Gene, 289: 191-199.
    CrossRef  |  Direct Link  |  
  232. Scorilas, A., A. Magklara, B.R. Hoffman, R.M. Bromberg, A. Bjartell and E.P. Diamandis, 2002. Highly sensitive array analysis using time resolved fluorescence and a novel streptavidin-based reagent. Anal. Sci., 17: 547-550.
    Direct Link  |  
  233. Scorilas, A., 2002. Polyadenylate Polymerase (PAP) and 3' end pre-mRNA processing: Function, assays, and association with disease. Crit. Rev. Clin. Lab. Sci., 39: 193-224.
    CrossRef  |  Direct Link  |  
  234. Papadopoulou, S., A. Scorilas, J. Yotis, N. Arnogianaki, G. Plataniotis, N. Agnanti and M. Talieri, 2002. Significance of urokinase-type plasminogen activator and Plasminogen Activator Inhibitor-1 (PAI-1) expression in human colorectal carcinomas. Tumor Biol., 23: 170-178.
    CrossRef  |  PubMed  |  Direct Link  |  
  235. Obiezu, C.V., A. Soosaipillai, K. Jung, C. Stephan, A. Scorilas, D.H. Howarth and E.P. Diamandis, 2002. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. Clin. Chem., 48: 1232-1240.
    Direct Link  |  
  236. Hoffman, B.R., D. Katsaros, A. Scorilas, P. Diamandis and S. Fracchioli et al., 2002. Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: A new independent unfavourable prognostic biomarker. Br. J. Cancer, 87: 763-771.
    CrossRef  |  Direct Link  |  
  237. Chang, A., G.M. Yousef, A. Scorilas, L. Grass, P. Sismondi, R. Ponzone and E.P. Diamandis, 2002. Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: An independent indicator of favourable prognosis in breast cancer. Br. J. Cancer, 86: 1457-1464.
    CrossRef  |  Direct Link  |  
  238. Yousef, G.M., L.G. Kyriakopoulou, A. Scorilas, S. Fracchioli and B. Ghiringhello et al., 2001. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: A new independent and favorable prognostic marker. Cancer Res., 61: 7811-7818.
    Direct Link  |  
  239. Yousef, G.M., A. Scorilas, K. Jung, L.K. Ashworth and E.P. Diamandis, 2001. Molecular Cloning of the human kallikrein 15 gene (KLK15): Up-regulation in prostate cancer. J. Biol. Chem., 276: 53-61.
    CrossRef  |  Direct Link  |  
  240. Scorilas, A., L. Kyriakopoulou, G.M. Yousef, L.K. Ashworth, A. Kwamie and E.P. Diamandis, 2001. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. Genomics, 72: 217-221.
    CrossRef  |  Direct Link  |  
  241. Scorilas, A., L. Kyriakopoulou, D. Katsaros and E.P. Diamandis, 2001. Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: Overexpression in aggressive ovarian cancer. Br. J. Cancer, 85: 190-198.
    CrossRef  |  Direct Link  |  
  242. Scorilas, A., G.M. Yousef, K. Jung, E. Rajpert-De Meyts, S. Carsten and E.P. Diamandis, 2001. Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors. Biochem. Biophys. Res. Commun., 285: 400-408.
    CrossRef  |  Direct Link  |  
  243. Scorilas, A., B. Bharaj, M. Giai and E.P. Diamandis, 2001. Codon 89 polymorphism in the human 5α-reductase gene in primary breast cancer. Br. J. Cancer, 84: 760-767.
    CrossRef  |  Direct Link  |  
  244. Scorilas, A., A. Karameris, N. Arnogiannaki, A. Ardavanis, P. Bassilopoulos, T. Trangas and M. Talieri, 2001. Overexpression of matrix-metalloproteinase-9 in human breast cancer: A potential favourable indicator in node-negative patients. Br. J. Cancer, 84: 1488-1496.
    CrossRef  |  Direct Link  |  
  245. Papadopoulou, S., A. Scorilas, N. Arnogianaki, B. Papapanayiotou and A. Tzimogiani, N. Agnantis and M. Talieri, 2001. Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa. Tumor Biol., 22: 383-389.
    CrossRef  |  Direct Link  |  
  246. Obiezu, C.V., A. Scorilas, D. Katsaros, M. Massobrio and G.M. Yousef et al., 2001. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients. Clin. Cancer Res., 7: 2380-2386.
    Direct Link  |  
  247. Obiezu, C.V., A. Scorilas, A. Magklara, M.H. Thornton, C.Y. Wang, F.Z. Stanczyk and E.P. Diamandis, 2001. Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 86: 1558-1561.
    CrossRef  |  Direct Link  |  
  248. Magklara, A., A. Scorilas, D. Katsaros, M. Massobrio and G.M. Yousef et al., 2001. The human KLK8 (neuropsin/ovasin) gene: Identification of two novel splice variants and its prognostic value in ovarian cancer. Clin. Cancer Res., 7: 806-811.
    Direct Link  |  
  249. Luo, L.Y., P. Bunting, A. Scorilas and E.P. Diamandis, 2001. Human kallikrein 10: A novel tumor marker for ovarian carcinoma? Clin. Chim. Acta, 306: 111-118.
    CrossRef  |  Direct Link  |  
  250. Luo, L.Y., D. Katsaros, A. Scorilas, S. Fracchioli and R. Piccinno et al., 2001. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin. Cancer Res., 7: 2372-2379.
    Direct Link  |  
  251. Kim, H., A. Scorilas, D. Katsaros, G.M. Yousef and M. Massobrio et al., 2001. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br. J. Cancer, 84: 643-650.
    CrossRef  |  Direct Link  |  
  252. Khosravi, J., A. Diamandi, J. Mistry and A. Scorilas, 2001. Insulin-like Growth Factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer. J. Clin. Endocrinol. Metab., 86: 694-699.
    CrossRef  |  Direct Link  |  
  253. Kalomenidis, I., D. Orphanidou, G. Papamichalis, T. Vassilakopoulos and A. Skorilas et al., 2001. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: Association with clinical characteristics. Lung, 179: 265-278.
    CrossRef  |  Direct Link  |  
  254. Yousef, G.M., A. Scorilas, A. Magklara, A. Soosaipillai and E.P. Diamandis, 2000. The KLK7 (PRSS6) gene, encoding for the stratum corneum chymotryptic enzyme is a new member of the human kallikrein gene family-genomic characterization, mapping, tissue expression and hormonal regulation. Gene, 254: 119-128.
    CrossRef  |  Direct Link  |  
  255. Yousef, G.M., A. Scorilas and E.P. Diamandis, 2000. Genomic organization, mapping, tissue expression and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family. Genomics, 63: 88-96.
    CrossRef  |  Direct Link  |  
  256. Yousef, G.M., A. Chang, A. Scorilas and E.P. Diamandis, 2000. Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem. Biophys. Res. Commun., 276: 125-133.
    CrossRef  |  Direct Link  |  
  257. Sklavounou, A., E. Chrysomali, A. Scorilas and A. Karameris, 2000. TNF-α expression and apoptosis-regulating proteins in oral lichen planus: A comparative immunohistochemical evaluation. J. Oral Pathol. Med., 29: 370-375.
    CrossRef  |  Direct Link  |  
  258. Scorilas, A., M.H. Black, M. Talieri and E.P. Diamandis, 2000. Genomic organization, physical mapping and expression analysis of the human protein arginine methyltransferase 1 gene. Biochem. Biophys. Res. Commun., 278: 349-359.
    CrossRef  |  PubMed  |  Direct Link  |  
  259. Scorilas, A., M. Talieri, A. Ardavanis, N. Courtis and E. Dimitriadis et al., 2000. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer. Cancer Res., 60: 5427-5433.
    Direct Link  |  
  260. Scorilas, A., H. Yu, A.R. Soosaipillai, A.K. Gregorakis and E.P. Diamandis, 2000. Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy. Clin. Chim. Acta, 292: 127-138.
    CrossRef  |  Direct Link  |  
  261. Scorilas, A., A. Bjartell, H. Lilja, C. Moller and E.P. Diamandis, 2000. Streptavidin-polyvinylamine conjugates labeled with a europium chelate: Applications in immunoassay, immunohistochemistry and microarrays. Clin. Chem., 46: 1450-1455.
    Direct Link  |  
  262. Scorilas, A. and E.P. Diamandis, 2000. Polyvinylamine-streptavidin complexes labeled with a europium chelator: A universal detection reagent for solid-phase time resolved fluorometric applications. Clin. Biochem., 33: 345-350.
    CrossRef  |  Direct Link  |  
  263. Obiezu, C.V., E.J. Giltay, A. Magklara, A. Scorilas, L. Gooren, H. Yu and E.P. Diamandis, 2000. Dramatic suppression of plasma and urinary prostate specific antigen and human glandular kallikrein by antiandrogens in male-to-female transsexuals. J. Urol., 163: 802-805.
    CrossRef  |  Direct Link  |  
  264. Obiezu, C.V., E.J. Giltay, A. Magklara, A. Scorilas and L.J. Gooren et al., 2000. Serum and urinary prostate-specific antigen and urinary human glandular kallikrein concentrations are significantly increased after testosterone administration in female-to-male transsexuals. Clin. Chem., 46: 859-862.
    PubMed  |  Direct Link  |  
  265. Nam, R.K., E.P. Diamandis, A. Toi, J. Trachtenberg and A. Magklara et al., 2000. Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate-specific antigen. J. Clin. Oncol., 18: 1036-1042.
    CrossRef  |  PubMed  |  Direct Link  |  
  266. Magklara, A., A. Scorilas, C. Stephan, G.O. Kristiansen, S. Hauptmann, K. Jung and E.P. Diamandis, 2000. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. Urology, 56: 527-532.
    CrossRef  |  Direct Link  |  
  267. Bharaj, B., A. Scorilas, M. Giai and E.P. Diamandis, 2000. TA repeat polymorphism of the 5α-reductase gene and breast cancer. Cancer Epidemiol. Prev. Biomarkers, 9: 387-393.
    Direct Link  |  
  268. Bharaj, B., A. Scorilas, E.P. Diamandis, M. Giai, M.A. Levesque, D.J. Sutherland and B.R. Hoffman, 2000. Breast cancer prognostic significance of a single nucleotide polymorphism in the proximal androgen response element of the prostate specific antigen gene promoter. Breast Cancer Res. Treat., 61: 111-119.
    CrossRef  |  Direct Link  |  
  269. Scorilas, A., T. Trangas, J. Yotis, C. Pateras and M. Talieri, 1999. Determination of c-myc amplification and overexpression in breast cancer patients: Evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis. Br. J. Cancer, 81: 1385-1391.
    CrossRef  |  Direct Link  |  
  270. Scorilas, A., J. Yotis, C. Pateras, T. Trangas and M. Talieri, 1999. Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis. Clin. Cancer Res., 5: 815-821.
    Direct Link  |  
  271. Scorilas, A., E.P. Diamandis, M.A. Levesque, A. Papanastasiou-Diamandi and M.J. Khosravi et al., 1999. Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: An independent favorable prognostic factor in node-positive patients. Clin. Cancer Res., 5: 1778-1785.
    Direct Link  |  
  272. Magklara, A., A. Scorilas, W.J. Catalona and E.P. Diamandis, 1999. The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA. Clin. Chem., 45: 1960-1966.
    Direct Link  |  
  273. Magklara, A., A. Scorilas, C. Lopez-Otín, F. Vizoso, A. Ruibal and E.P. Diamandis, 1999. Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid. Clin. Chem., 45: 1774-1780.
    Direct Link  |  
  274. Scorilas, A., N. Courtis, J. Yotis, M. Talieri, M. Michailakis and T. Trangas, 1998. Poly(A)polymerase activity levels in breast tumour cytosols. J. Exp. Clin. Cancer Res., CR, 17: 511-518.
    Direct Link  |  
  275. Ardavanis, A., A Scorilas, A. Loukeri, F. Gerakini and G. Pissakas et al., 1998. Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence. Anticancer Res., 18: 2885-2890.
    Direct Link  |  
  276. Ardavanis, A., F. Gerakini, A. Amanatidou, A. Scorilas and C. Pateras et al., 1997. Relationships between cathepsin-D, pS2 protein and hormonal receptors in breast cancer cytosols: inconsistency with their established prognostic significance. Anticancer Res., 17: 3665-3669.
    Direct Link  |  
  277. Ardavanis, A., A. Scorilas, A. Amanatidou, F. Gerakini and I. Missitzis et al., 1997. Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer. Anticancer Res., 17: 1405-1409.
    Direct Link  |  
  278. Scorilas, A., J. Yotis, K. Stravolemos, D. Gouriotis and A. Keramopoulos et al., 1995. C-erbB-2 overexpression may be used as an independent prognostic factor for breast cancer patients. Anticancer Res., 15: 1543-1547.
    Direct Link  |  
  279. Scorilas, A., J. Yotis, D. Gouriotis, A. Keramopoulos, K. Ampela, T. Trangas and M. Talieri, 1993. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients. Anticancer Res., 13: 1895-1900.
    Direct Link  |